🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Acasti Pharma Inc - QTRLY Loss Per Share $0.15

Published 2019-08-14, 08:16 a/m
© Reuters.  BRIEF-Acasti Pharma Inc - QTRLY Loss Per Share $0.15
ACST
-

Acasti Pharma Inc ACST.V :

* ACASTI PHARMA PROVIDES BUSINESS UPDATE FOR THE FIRST QUARTER OF FISCAL 2020

* ACASTI PHARMA INC - ON TRACK TO REPORT TOPLINE RESULTS FOR TRILOGY 1 IN DECEMBER 2019 AND TRILOGY 2 IN JANUARY 2020

* ACASTI PHARMA INC - FULLY FUNDED BEYOND COMPLETION OF PHASE 3 STUDIES

* ACASTI PHARMA INC - AT JUNE 30, 2019, ACASTI HAD $25.4 MILLION OF CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES

* ACASTI PHARMA INC - QTRLY LOSS PER SHARE $0.15

* ACASTI PHARMA - WILL NEED TO RAISE ADDITIONAL CAPITAL IN FUTURE TO COMPLETE FUNDING OF PREPARATION & FILING NDA, AND US COMMERCIAL LAUNCH ACTIVITIES

* ACASTI - THERE IS MATERIAL UNCERTAINTY ABOUT CO'S ABILITY TO CONTINUE AS GOING CONCERN & TO REALIZE ASSETS % DISCHARGE LIABILITIES IN NORMAL COURSE

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.